Fenofibrate for Patients With COVID-19 Requiring Hospitalization
Conditions: Corona Virus Disease (COVID-19); Respiratory Distress Syndrome; SARS-CoV-2 Infection Interventions: Drug: TriCor® 145mg tablets; Other: Usual Care; Other: Placebo Sponsors: Hebrew University of Jerusalem; Barzilai Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials